Comment from The Catholic Medical Association
AnonymousOpposeAdvocacy
Summary: The Catholic Medical Association (CMA) opposes the petition to reduce or eliminate FDA safety regulations on mifepristone, arguing that the current regulations are necessary to address serious adverse effects and ethical concerns. They advocate for strengthening existing safeguards, including mandatory in-person consultations and more comprehensive informed consent regarding risks and alternatives.
Edit to Comment Tracking Number: me1-pfsy-mxhq: The Catholic Medical Association (CMA), the largest association of Catholic physicians and healthcare professionals in the United States, submits the attached comments in response to the above-referenced Citizen Petition. This petition seeks to reduce or eliminate the FDA’s current safety regulations on the chemical abortion drug mifepristone, specifically concerning the Risk Evaluation and Mitigation Strategy (REMS) and Elements to Assure Safe Use (EASU), including Prescriber, Patient, and Pharmacy Certification elements. The CMA strongly opposes the requested changes to mifepristone’s REMS and EASU oversight based on two primary concerns: 1. Reliance on Inadequate and Biased Data; 2. Ethical and Societal Consequences of Chemical Abortion.